HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandro De Falco Selected Research

Rheumatoid Arthritis

3/2015Placental growth factor-1 and -2 induce hyperplasia and invasiveness of primary rheumatoid synoviocytes.
2/2009Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandro De Falco Research Topics

Disease

18Neoplasms (Cancer)
03/2024 - 08/2002
13Pathologic Neovascularization
04/2021 - 01/2004
8Inflammation (Inflammations)
03/2024 - 03/2008
7Choroidal Neovascularization
04/2021 - 04/2009
5Neoplasm Metastasis (Metastasis)
03/2024 - 03/2008
5Ischemia
04/2021 - 08/2002
3Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 04/2015
3Macular Degeneration (Age-Related Maculopathy)
01/2021 - 01/2016
3Hypoxia (Hypoxemia)
05/2017 - 04/2014
3Arthritis (Polyarthritis)
01/2010 - 01/2004
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 02/2018
2Retinal Diseases
01/2021 - 02/2018
2Blindness (Hysterical Blindness)
01/2020 - 12/2012
2Parkinson Disease (Parkinson's Disease)
01/2020 - 08/2010
2Macular Edema
10/2019 - 11/2017
2Rheumatoid Arthritis
03/2015 - 02/2009
2Carcinoma (Carcinomatosis)
06/2011 - 01/2011
2Experimental Arthritis
01/2010 - 02/2009
1Carcinogenesis
03/2024
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2021
1Pathologic Processes
01/2021
1Retinal Vein Occlusion
02/2018
1Vascular Diseases (Vascular Disease)
02/2018
1Glioma (Gliomas)
05/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2016
1Corneal Neovascularization
01/2016
1Fibrosarcoma
01/2016
1Ulcer
01/2015
1T-Cell Leukemia (Leukemia, T Cell)
03/2014
1Colonic Neoplasms (Colon Cancer)
01/2014
1Teratocarcinoma
01/2013
1Melanoma (Melanoma, Malignant)
06/2011
1Peripheral Arterial Disease
03/2010
1Intermittent Claudication
03/2010
1Hyperplasia
01/2010
1Breast Neoplasms (Breast Cancer)
08/2008
1Atherosclerosis
01/2004
1Body Weight (Weight, Body)
01/2004

Drug/Important Bio-Agent (IBA)

19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 08/2002
9Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2018 - 01/2004
5Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
07/2015 - 03/2008
4Retinaldehyde (Retinal)IBA
04/2021 - 02/2018
3Peptides (Polypeptides)IBA
04/2015 - 01/2010
2Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021 - 02/2009
2Vascular Endothelial Growth Factor BIBA
01/2021 - 07/2015
2afliberceptIBA
10/2019 - 11/2017
2Bevacizumab (Avastin)FDA Link
04/2015 - 01/2014
2Collagen Type II (Type II Collagen)IBA
01/2010 - 02/2009
1Biomarkers (Surrogate Marker)IBA
03/2024
1InflammasomesIBA
03/2024
1RNA (Ribonucleic Acid)IBA
03/2024
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2021
1LigandsIBA
01/2021
1AntibodiesIBA
12/2020
1SynucleinsIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
10/2019
1Prostaglandins FIBA
02/2018
1Oxygen (Dioxygen)IBA
02/2018
1Transcription Factors (Transcription Factor)IBA
05/2017
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2016
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2015
1Monoclonal AntibodiesIBA
04/2015
1Irinotecan (Camptosar)FDA LinkGeneric
04/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2015
1AntioxidantsIBA
01/2015
1Histones (Histone)IBA
04/2014
1ThioredoxinsIBA
03/2014
1atractyligenineIBA
03/2014
1ent-kaurane 15-ketoatractyligenin methyl esterIBA
03/2014
1nutlin 3IBA
10/2013
1entinostat (MS 275)IBA
01/2013
1Therapeutic UsesIBA
01/2013
1Histone Deacetylase InhibitorsIBA
01/2013
1Angiogenesis InhibitorsIBA
07/2011
1amentoflavoneIBA
06/2011
1Carnitine (L-Carnitine)FDA LinkGeneric
03/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2010
1AutoantibodiesIBA
01/2010
1Neuropilin-1IBA
01/2010
1Toll-Like Receptor 3IBA
04/2009
1Double-Stranded RNA (RNA, Double Stranded)IBA
04/2009
1Small Interfering RNA (siRNA)IBA
04/2009
1CytokinesIBA
02/2009
1Placenta Growth FactorIBA
02/2009
1Interleukin-6 (Interleukin 6)IBA
02/2009
1ErbB Receptors (EGF Receptor)IBA
08/2008
1Phosphotransferases (Kinase)IBA
08/2008
1vandetanib (ZD6474)IBA
08/2008
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
05/2006
1Citrate (si)-Synthase (Synthase, Citrate)IBA
01/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2004

Therapy/Procedure

6Lasers (Laser)
04/2021 - 12/2012
5Therapeutics
01/2020 - 08/2010
1Precision Medicine
12/2023
1Intravitreal Injections
04/2015
1Subcutaneous Injections
01/2010
1Sutures (Suture)
04/2009